Cabaletta Bio, Inc.
CABA
$3.53
-$0.11-2.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.87% | -52.19% | -60.35% | -64.91% | -71.21% |
| Total Depreciation and Amortization | -3.80% | 11.84% | 22.19% | 24.00% | 19.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.01% | 56.11% | 75.98% | 89.44% | 93.03% |
| Change in Net Operating Assets | -123.53% | 774.38% | 329.47% | 169.31% | 1,495.05% |
| Cash from Operations | -48.58% | -45.75% | -41.78% | -46.37% | -64.75% |
| Capital Expenditure | 44.41% | 30.69% | 14.03% | -95.17% | -221.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -199.06% | -325.82% | -193.08% | 205.85% | 327.44% |
| Cash from Investing | -206.30% | -342.24% | -206.76% | 198.82% | 310.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -597.99% | -- | -- | -- | -- |
| Issuance of Common Stock | 747.93% | 1.29% | 1.33% | -97.05% | -93.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 759.36% | -3.95% | -3.11% | -97.80% | -93.78% |
| Foreign Exchange rate Adjustments | 195.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.61% | -300.34% | -165.30% | -153.36% | -126.23% |